Spots Global Cancer Trial Database for Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Official Title: A Phase I Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Study ID: NCT00273936
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the safety and maximum tolerated dose, pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced hematologic malignancies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Clinical Research Center, Tucson, Arizona, United States
Stanford Cancer Center, Stanford, California, United States
George Washington University, Washington, District of Columbia, United States
Ohio State University, James Cancer Hospital Comprehensive Cancer Center, Columbus, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
